CRINETICS PHARMACEUTICALS IN (CRNX) Institutional Ownership Changes & 13F Activity
CRINETICS PHARMACEUTICALS IN (CRNX). Institutional ownership data tracks hedge funds, asset managers, and other institutional investors based on recent SEC Form 13F filings (Q4 2025). This page analyzes institutional buying and selling activity, new holdings, and sold-out positions in the latest reporting period. Notable filers include Fmr Llc, Wellington Management Group Llp, Driehaus Capital Management Llc, Price T Rowe Associates Inc, and Janus Henderson Group Plc.
| Institution | Type | Change in shares | Change Position % | Shares | Reported stock balance | Portfolio quarter | Filing date |
|---|---|---|---|---|---|---|---|
| Cornerstone Financial Management Llc | Buy | +34 | — | 34 | $1.58K | Q4 2025 | Aug 28, 2026 |
| Advisors Asset Management, Inc. | Sell | -6,652 | -100.0% | 0 | $0.00 | Q4 2025 | Aug 26, 2026 |
| Ensign Peak Advisors, Inc | Sell | -19,392 | -6.6% | 275,616 | $12.83M | Q4 2025 | Aug 18, 2026 |
| Bell Investment Advisors, Inc | Buy | +17 | — | 17 | $792.00 | Q4 2025 | Feb 24, 2026 |
| Raymond James Financial Inc | Buy | +33,354 | — | 33,354 | $1.55M | Q4 2025 | Feb 18, 2026 |
| Mackenzie Financial Corp | Buy | +5,666 | — | 5,666 | $267.98K | Q4 2025 | Feb 18, 2026 |
| Fmr Llc | Buy | +14,293,775 | — | 14,293,775 | $665.38M | Q4 2025 | Feb 17, 2026 |
| Wellington Management Group Llp | Buy | +8,037,889 | — | 8,037,889 | $374.16M | Q4 2025 | Feb 17, 2026 |
| Driehaus Capital Management Llc | Buy | +6,387,740 | — | 6,387,740 | $297.35M | Q4 2025 | Feb 17, 2026 |
| Price T Rowe Associates Inc | Buy | +5,224,387 | — | 5,224,387 | $243.20M | Q4 2025 | Feb 17, 2026 |
| Janus Henderson Group Plc | Buy | +4,440,691 | — | 4,440,691 | $206.60M | Q4 2025 | Feb 17, 2026 |
| Ecor1 Capital, Llc | Buy | +4,288,120 | — | 4,288,120 | $199.61M | Q4 2025 | Feb 17, 2026 |
| Point72 Asset Management, L.P. | Buy | +2,337,034 | — | 2,337,034 | $108.79M | Q4 2025 | Feb 17, 2026 |
| Paradigm Biocapital Advisors Lp | Buy | +2,210,774 | — | 2,210,774 | $102.91M | Q4 2025 | Feb 17, 2026 |
| Baker Bros. Advisors Lp | Buy | +1,648,869 | — | 1,648,869 | $76.75M | Q4 2025 | Feb 17, 2026 |
| Novo Holdings A/S | Buy | +1,625,000 | — | 1,625,000 | $75.64M | Q4 2025 | Feb 17, 2026 |
| Rtw Investments, Lp | Buy | +1,351,326 | — | 1,351,326 | $62.90M | Q4 2025 | Feb 17, 2026 |
| First Light Asset Management, Llc | Buy | +1,194,263 | — | 1,194,263 | $55.59M | Q4 2025 | Feb 17, 2026 |
| Orbimed Advisors Llc | Buy | +999,000 | — | 999,000 | $46.50M | Q4 2025 | Feb 17, 2026 |
| Hood River Capital Management Llc | Buy | +897,403 | — | 897,403 | $41.77M | Q4 2025 | Feb 17, 2026 |
| Bank Of America Corp | Buy | +801,314 | — | 801,314 | $37.30M | Q4 2025 | Feb 17, 2026 |
| Northern Trust Corp | Buy | +769,823 | — | 769,823 | $35.84M | Q4 2025 | Feb 17, 2026 |
| Ameriprise Financial Inc | Buy | +601,190 | — | 601,190 | $27.99M | Q4 2025 | Feb 17, 2026 |
| Adar1 Capital Management, Llc | Buy | +309,368 | — | 309,368 | $14.40M | Q4 2025 | Feb 17, 2026 |
| Millennium Management Llc | Buy | +300,335 | — | 300,335 | $13.98M | Q4 2025 | Feb 17, 2026 |
| Cormorant Asset Management, Lp | Buy | +300,000 | — | 300,000 | $13.96M | Q4 2025 | Feb 17, 2026 |
| Citadel Advisors Llc | Buy | +254,720 | — | 254,720 | $11.86M | Q4 2025 | Feb 17, 2026 |
| Balyasny Asset Management L.P. | Buy | +233,197 | — | 233,197 | $10.86M | Q4 2025 | Feb 17, 2026 |
| Gordonmd Global Investments Lp | Buy | +224,135 | — | 224,135 | $10.43M | Q4 2025 | Feb 17, 2026 |
| Rice Hall James & Associates, Llc | Buy | +171,830 | — | 171,830 | $8.00M | Q4 2025 | Feb 17, 2026 |
Frequently asked questions about CRNX activity
Which institutional owners are buying CRNX?
Institutional owners buying CRNX include investors who have either initiated new positions or increased their existing holdings based on recent SEC 13F filings. The activity table above highlights which funds added shares in the latest reporting periods and how their positions changed over time.
What does "buy" mean in CRNX activity?
"Buy" means an investor increased their reported position in CRNX compared to the prior reporting period. This reflects growing exposure to CRINETICS PHARMACEUTICALS IN (CRNX) rather than necessarily a brand-new position (though new positions also appear as buys when prior quantity was zero).
Is institutional interest in CRNX increasing?
Institutional interest in CRNX can be assessed by comparing the number of tracked funds adding or increasing positions versus those trimming or exiting across the periods shown. A higher number of additions typically signals increasing participation among large filers, but it should be read alongside position sizes and the full table.
Related CRNX Institutional Insights
- CRNX Overview
- CRNX 13F Institutional Holders
- CRNX Superinvestors
- Healthcare Sector Institutional Ownership
- Healthcare Sector Portfolio Overlap
- Institutional Portfolio Overlap & Shared Holdings
- Most Bought Healthcare Stocks By Institutional Investors
- Most Sold Healthcare Stocks By Institutional Investors
- CRNX Insider Trading & SEC Form 4 Activity
- CRNX Articles
- Top Institutional Investor Stock Rankings